Study to Assess the Safety and Biological Activity of AMX0035 for the Treatment of Alzheimer's Disease (PEGASUS)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.

ClinicalTrials.gov Identifier: NCT03533257

Recruitment Status : Active, not recruiting

First Posted : May 23, 2018

Last Update Posted : April 20, 2020

Sponsor:

Collaborators:

Alzheimer's Drug Discovery Foundation

Alzheimer's Association

Information provided by (Responsible Party):

Amylyx Pharmaceuticals Inc.

Study Details
Tabular View
No Results Posted
Disclaimer
How to Read a Study Record

No Study Results Posted on ClinicalTrials.gov for this Study

About Study Results Reporting on ClinicalTrials.gov

Recruitment Status :	Active, not recruiting
Estimated Primary Completion Date :	October 1, 2020
Estimated Study Completion Date :	December 1, 2020

To Top